Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation

Cytotoxic T-lymphocyte therapy for post-transplant lymphoproliferative disorder after solid organ transplantation in children

(2018) Fang Kuan Chiou et al.   PEDIATRIC TRANSPLANTATION

Dissecting Epstein-Barr Virus-Specific T-Cell Responses After Allogeneic EBV-Specific T-Cell Transfer for Central Nervous System Posttransplant Lymphoproliferative Disease

(2018) Rebecca E. Schultze-Florey et al.   Frontiers in Immunology

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

(2017) Ifigeneia Tzannou et al.   JOURNAL OF CLINICAL ONCOLOGY

Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial

(2017) Ralf U. Trappe et al.   JOURNAL OF CLINICAL ONCOLOGY

Towards ‘off-the-shelf’ genetically modified T cells: prolonging functional engraftment in mice by CD8 veto T cells

(2017) N Or-Geva et al.   LEUKEMIA

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

(2016) S. H. Swerdlow et al.   BLOOD

Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes

(2016) Swati Naik et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Epstein–Barr virus microRNAs reduce immune surveillance by virus-specific CD8+T cells

(2016) Manuel Albanese et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Post-transplant lymphoproliferative disorders: From epidemiology to pathogenesis-driven treatment

(2015) Maria Raffaella Petrara et al.   CANCER LETTERS

Current concepts in the diagnosis and management of cytokine release syndrome

(2014) D. W. Lee et al.   BLOOD

Monitoring of chimerism following allogeneic haematopoietic stem cell transplantation (HSCT): Technical recommendations for the use of Short Tandem Repeat (STR) based techniques, on behalf of the United Kingdom National External Quality Assessment Service

(2014) Jordan R. Clark et al.   BRITISH JOURNAL OF HAEMATOLOGY

Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease

(2014) Mark A. Vickers et al.   BRITISH JOURNAL OF HAEMATOLOGY

Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients

(2014) R. San-Juan et al.   CLINICAL MICROBIOLOGY AND INFECTION

T-cell Therapy Using a Bank of EBV-specific Cytotoxic T Cells

(2014) Géraldine Gallot et al.   JOURNAL OF IMMUNOTHERAPY

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

(2013) A. M. Leen et al.   BLOOD

EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era

(2013) C P Fox et al.   BONE MARROW TRANSPLANTATION

Molecular Pathogenesis of B-Cell Posttransplant Lymphoproliferative Disorder: What Do We Know So Far?

(2013) J. Morscio et al.   Clinical & Developmental Immunology

Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus–Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

(2013) Jan Styczynski et al.   CLINICAL INFECTIOUS DISEASES

Rapid Salvage Treatment With Virus-Specific T Cells for Therapy-Resistant Disease

(2012) M. Uhlin et al.   CLINICAL INFECTIOUS DISEASES

Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1–Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation

(2012) Vanya Icheva et al.   JOURNAL OF CLINICAL ONCOLOGY

Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections

(2012) Ulrike Gerdemann et al.   MOLECULAR THERAPY

The Seville Expert Workshop for Progress in Posttransplant Lymphoproliferative Disorders

(2012) Denis Glotz et al.   TRANSPLANTATION

Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation

(2011) E. Doubrovina et al.   BLOOD

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial

(2011) Ralf Trappe et al.   LANCET ONCOLOGY

Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes

(2010) J. N. Barker et al.   BLOOD

High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts

(2010) M Hoegh-Petersen et al.   BONE MARROW TRANSPLANTATION

Epstein-Barr virus evasion of CD8+ and CD4+ T cell immunity via concerted actions of multiple gene products

(2008) Maaike E. Ressing et al.   SEMINARS IN CANCER BIOLOGY